| ［1］Dai YCh, Zhou LW, Yang ZhL, et al. A revised checklist of edible fungi in China［J］. Mycosystema, 2010, 29(1): 1-21. (in Chinese)
戴玉成, 周丽伟, 杨祝良, 等. 中国食用菌名录［J］. 菌物学报， 2010,29 (1):1-21.
［2］Feng J, Qin ShL, Hu B, et al.Chemical constituents of fruiting bodies of Chroogomphus rutilus and their biological activities［J］. Mycosystema, 2014, 33(2): 355-364. (in Chiense)
冯建, 秦淑亮, 胡兵, 等. 色钉菇子实体化学成分及其生物活性初探［J］. 菌物学报， 2014， 33(2): 355-364.
［3］Sun H. Studies on the macrofungus Resources in Yanshan mountain of hebei province and antioxidant activity of five kinds of mushrooms［D］. Hebei Normal University, 2011: 25-42. (in Chinese)
孙红. 河北省燕山地区野生高等真菌资源调查及五种子实体抗氧化活性研究［D］. 河北师范大学，2011：25-42.
［4］Zuo L, Motherwell MS. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson’s disease［J］. Gene, 2013,532(1): 18-23.
［5］Ciron C, Zheng L, Bobela W, et al. PGC1alpha activity in nigral dopamine neurons determines vulnerability to alphasynuclein［J］. Acta Neuropathol Commun, 2015, 3(1): 16-35.
［6］Zhang XQ, Sun H, Wang LA, et al. Protective effects of crudepolysaccharides from Chroomgomphus rutilus on dopaminergic neurons impaered by MPTP in mice［J］. Mycosystema, 2011, 30(1): 77-84. (in Chinese)
张雪倩, 孙红, 王立安，等. 色钉菇粗多糖对小鼠DA能神经元MPTP损伤的保护作用［J］. 菌物学报， 2011， 30 (1): 77-84.
［7］Zhang XQ, Wang YQ, Wang LA, et al. Protective effects of crude polysaccharides from Chroomgomphus rutilus on SH-SY5Y cells impaired by MPP+［J］. Acta Physiologica Sinica, 2013, 65(2): 210-216. (in Chinese)
张雪倩, 王艳芹, 王立安, 等. 色钉菇粗多糖对MPP+损伤的SH-SY5Y细胞的保护作用［J］. 生理学报， 2013， 65 (2): 210-216.
［8］Gaki GS, Papavassiliou AG. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson’sdisease［J］. Neuromolecular Med, 2014, 16(2): 217-230.
［9］Jin H, Kanthasamy A, Ghosh A, et al. Mitochondria-targeted antioxidants for treatment of Parkinson’s disease: preclinical and clinical outcomes［J］. Biochim Biophys Acta, 2014, 1842(8): 1282-1294.
［10］Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: a meta-analysis［J］. Lancet Neurol, 2005, 4(6): 362-365.
［11］Weber CA, Ernst ME. Antioxidants, supplements, and Parkinson’s disease［J］. Ann Pharmacother, 2006, 40(5): 935-938.
［12］Li TT, Liang YCh. In vitro models of parkinson disease［J］. Medical Recapitulate, 2013, 19(6): 1003-1006. (in Chinese)
李婷婷, 梁迎春. 帕金森病体外细胞模型［J］. 医学综述, 2013, 19(6): 1003-1006.
［13］Chen L, Zhang LH, Zhang JF, et al. Parkinson’s disease cells models and its experimental research［J］. Health Research, 2013, 33(3): 179-182. (in Chinese)
陈璐, 张丽慧, 张家凤, 等. 帕金森病细胞模型及实验研究［J］. 健康研究, 2013, 33(3): 179-182.
［14］Giordano S, Darley-Usmar V, Zhang J. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease［J］. Redox Biol, 2014, 2（1）: 82-90. |
